Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioNTech SE BNTX

Healthcare Biotechnology
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a... see more

Recent & Breaking News (NDAQ:BNTX)

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX

Newsfile February 19, 2024

Levi & Korsinsky Notifies Shareholders of BioNTech SE(BNTX) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire February 19, 2024

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the Firm

Newsfile February 19, 2024

BioNTech Deadline Alert

Newsfile February 19, 2024

Levi & Korsinsky Reminds BioNTech SE Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTX

Accesswire February 19, 2024

March 12, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BNTX

Accesswire February 19, 2024

BNTX LAWSUIT ALERT: Levi & Korsinsky Notifies BioNTech SE Investors of a Class Action Lawsuit and Upcoming Deadline

Accesswire February 18, 2024

BNTX ALERT: Kessler Topaz Meltzer & Check, LLP Reminds BioNTech SE (BNTX) Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm

Accesswire February 18, 2024

BioNTech SE Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 12, 2024 to Discuss Your Rights - BNTX

Accesswire February 18, 2024

BNTX SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds BioNTech SE Investors to Join the Class Action Lawsuit!

Accesswire February 18, 2024

Levi & Korsinsky Notifies BioNTech SE Investors of a Class Action Lawsuit and Upcoming Deadline - BNTX

Accesswire February 17, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTech SE of Class Action Lawsuit and Upcoming Deadlines - BNTX

Newsfile February 17, 2024

ROSEN, LEADING INVESTOR COUNSEL, Encourages BioNTech SE Investors to Secure Counsel Before Important Deadline in Securities Class Action - BNTX

PR Newswire February 17, 2024

BioNTech Shareholder Alert

Newsfile February 17, 2024

Kessler Topaz Meltzer & Check, LLP Reminds BNTX Investors of March 12, 2024 Deadline in Securities Fraud Class Action against of BioNTech SE (BNTX) and Urges Investors with Substantial Losses to Contact the Firm

PR Newswire February 17, 2024

Investors in BioNTech SE Should Contact Levi & Korsinsky Before March 12, 2024 to Discuss Your Rights - BNTX

Accesswire February 16, 2024

BIONTECH SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directly To Discuss Their Options

PR Newswire February 16, 2024

BioNTech SE Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 12, 2024 to Discuss Your Rights - BNTX

Accesswire February 16, 2024

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the Firm

Newsfile February 16, 2024

Shareholders that lost money on BioNTech SE (BNTX) should contact Levi & Korsinsky about pending Class Action - BNTX

PR Newswire February 16, 2024